Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXAGEN INC. | 247,236 | reported | 04 Mar 2024 | tx 13+362,635−32,251 |
| FATE THERAPEUTICS INC | 75,000 | reported | 15 Jan 2026 | tx 4+550,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jan 2026 | GRANT_AWARD | FATE THERAPEUTICS INC | 25,000 | 0.00 USD | |
| 15 Jan 2026 | GRANT_AWARD | FATE THERAPEUTICS INC | 75,000 | 0.00 USD | deriv |
| 20 Oct 2025 | GRANT_AWARD | FATE THERAPEUTICS INC | 75,000 | 0.00 USD | |
| 20 Oct 2025 | GRANT_AWARD | FATE THERAPEUTICS INC | 375,000 | 0.00 USD | deriv |
| 04 Mar 2024 | SALE | EXAGEN INC. | 3,487 | 1.91 USD | |
| 04 Mar 2024 | SALE | EXAGEN INC. | 9,297 | 1.91 USD | |
| 20 Feb 2024 | GRANT_AWARD | EXAGEN INC. | 75,000 | 0.00 USD | |
| 06 Feb 2024 | SALE | EXAGEN INC. | 6,738 | 1.95 USD | |
| 02 Mar 2023 | SALE | EXAGEN INC. | 3,667 | 2.30 USD | |
| 27 Feb 2023 | GRANT_AWARD | EXAGEN INC. | 100,000 | 0.00 USD | |
| 08 Feb 2023 | SALE | EXAGEN INC. | 5,821 | 2.69 USD | |
| 01 Mar 2022 | TAX_WITHHOLDING | EXAGEN INC. | 3,241 | 7.12 USD | |
| 04 Feb 2022 | GRANT_AWARD | EXAGEN INC. | 63,500 | 0.00 USD | |
| 23 Feb 2021 | GRANT_AWARD | EXAGEN INC. | 37,500 | 0.00 USD | |
| 23 Feb 2021 | GRANT_AWARD | EXAGEN INC. | 12,500 | 0.00 USD | deriv |
| 09 Jan 2020 | GRANT_AWARD | EXAGEN INC. | 52,500 | 0.00 USD | deriv |
| 18 Sept 2019 | GRANT_AWARD | EXAGEN INC. | 21,635 | 0.00 USD | deriv |